Clinical Trial

A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
laparoscopic pancreaticoduodenectomy(LPD) and Robot Pancreaticoduodenectomy (RPD), as two minimally invasive methods of pancreaticoduodenectomy(PD), have obvious advantages over traditional open pancreaticoduodenectomy(OPD) in terms of reducing surgical trauma and hospitalization time, but there are few studies on their perioperative safety and prognostic effects.However, there are few studies on the perioperative safety and prognostic effects of both procedures. In this trial, the perioperative data and prognosis of both procedures were collected and analyzed through a prospective, multicenter approach to investigate the advantages and disadvantages of both procedures.
Trial Details
NCT Number NCT05755607
Lead Sponsor The First Affiliated Hospital of University of South China
Conditions Pancreatic Cancer, Common Bile Duct Diseases, Periampullary Carcinoma
Enrollment 200 participants
Start Date 2023-06-01
Primary Completion 2028-06-01 (estimated)
Study Completion 2031-07-01 (estimated)
Updated on ClinicalTrials.gov 2023-03-06